GregoryPeterKaufmanMD

PubMed

• Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy.
  Penny Fang, Chelsea C Pinnix, Susan Y Wu, Hans C Lee, Krina K Patel, Neeraj Saini, Melody R Becnel, Gregory Kaufman, Sheeba K Thomas, Robert Z Orlowski, Behrang Amini,...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 May 1
• 2 citations
  Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple M...
  B R Shank, B Primeaux, E K Yeung, S B Horowitz, I Y Lee, L Roccograndi, L Feng, G P Kaufman, H C Lee, E E Manasanch, K K Patel, R Z Orlowski, D M Weber, M R Becnel, S ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Apr 1
• 3 citations
  Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
  Meera Mohan, Melody Renee Becnel, Urvi A Shah, Huaying Dong, Sravani Gundarlapalli, Timothy Peterson, Jennifer S Orozco, Sandra Horowitz, Saurabh Chhabra, Binod Dhakal...> ;American Journal of Hematology. 2022 Jul 1
• 2 citations
  Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell Transplantation.
  Aimaz Afrough, Oren Pasvolsky, Junsheng Ma, Samer Srour, Qaiser Bashir, Neeraj Saini, Chitra Hosing, Uday R Popat, Partow Kebriaei, Ruby Delgado, Muhammad R Ullah, Reg...> ;Transplantation and Cellular Therapy. 2022 Jun 1
• Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma.
  Aimaz Afrough, Leonard C Alsfeld, Denái R Milton, Ruby Delgado, Uday R Popat, Yago Nieto, Partow Kebriaei, Betul Oran, Neeraj Saini, Samer Srour, Chitra Hosing, Faisal...> ;Transplantation and Cellular Therapy. 2023 Apr 1
• 7 citations
  KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma.
  Mahmoud R Gaballa, Junsheng Ma, Mikael Rauf, Roland Bassett, Oren Pasvolsky, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Jeremy Ramdial, Yago Nieto, Reg...> ;Bone Marrow Transplantation. 2022 Jul 1
• 8 citations
  Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance
  Mahmoud R Gaballa, Junsheng Ma, Mark R Tanner, Taha Al-Juhaishi, Qaiser Bashir, Samer A Srour, Neeraj Saini, Jeremy L Ramdial, Yago Nieto, Regan Murphy, Katayoun Rezva...> ;Leukemia & Lymphoma. 2021 Oct 22
• 6 citations
  Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy.
  Guy Handley, Fareed Khawaja, Divya S. Kondapi, Hun J. Lee, Gregory P. Kaufman, Sattva S. Neelapu, Luis Fayad, Sudhakar Tummala, Linda Chi, Paolo Strati, Victor E. Mula...> ;International Journal of Infectious Diseases. 2021 Sep 29
• A Rare Case of Pediatric Amyloidosis Presenting as Upper Gastrointestinal Bleeding.
  Peace N. Dike, Maria M. Pereira, Gregory P. Kaufman, Kalyani R. Patel, Deborah Schady, Adam M. Vogel, Kristin L. Van Buren, Douglas S. Fishman> ;Journal of Pediatric Gastroenterology and Nutrition. 2021 Sep 22
• 8 citations
  Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma.
  Samer A. Srour, Denái R. Milton, Qaiser Bashir, Yago Nieto, Neeraj Saini, May Daher, Jeremy Ramdial, Jin Im, Chitra Hosing, Ruby Delgado, Elisabet E. Manasanch, Hans C...> ;Haematologica. 2021 Aug 19
• 3 citations
  Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide-based maintenance therapy.
  Chutima Kunacheewa, Lei Feng, Elisabet E. Manasanch, Qaiser Bashir, Krina K. Patel, Rohtesh S. Mehta, Gregory P. Kaufman, Samer A. Srour, Neeraj Saini, Swaminathan P. ...> ;British Journal of Haematology. 2021 Mar 21
• 3 citations
  Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis
  Gregory P. Kaufman, Claudio Cerchione> ;Frontiers in Oncology. 2021 Feb 3
• 3 citations
  Gene expression profiling predicts relapse-free and overall survival in newly diagnosed myeloma patients treated with novel therapies
  Elisabet E. Manasanch, David Berrios, Eric Fountain, Catherine M. Claussen, Tammy Chuang, Gregory P. Kaufman, Behrang Amini, Qaiser Bashir, Yago Nieto, Muzaffar H. Qaz...> ;British Journal of Haematology. 2021 Jan 24
• 8 citations
  Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis.
  Ali M. Agha, Nicolas Palaskas, Amit R. Patel, Jeanne M. DeCara, Purvi Parwani, Cezar Iliescu, Jean B. Durand, Peter Kim, Saamir Hassan, Gregory W. Gladish, Hans C. Lee...> ;Frontiers in Cardiovascular Medicine. 2021 Jan 1
• 3 citations
  SARS-CoV-2 in multiple myeloma: initial observation and management.
  Elisabet E. Manasanch, Victor E. Mulanovich, Joanna Grace M. Manzano, Maria Susan Gaeta, Melody R. Becnel, Gregory P. Kaufman, Hans C. Lee, Behrang Amini, Sheeba K. Th...> ;Leukemia & Lymphoma. 2020 Jun 17
• 34 citations
  Organ responses with daratumumab therapy in previously treated AL amyloidosis.
  Alfred Chung, Gregory P. Kaufman, Surbhi Sidana, Erik Eckhert, Stanley L. Schrier, Richard A. Lafayette, Sally Arai, Ronald M. Witteles, Michaela Liedtke> ;Blood Advances. 2020 Feb 11
• 8 citations
  Grading cardiac response in AL amyloidosis: implications for relapse and survival
  Erik Eckhert, Ronald M. Witteles, Gregory P. Kaufman, Richard A. Lafayette, Sally Arai, Stanley L. Schrier, Michelle M. O’Shaughnessy, Michaela Liedtke> ;British Journal of Haematology. 2019 Jul 1
• 49 citations
  Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases
  Suheil Albert Atallah-Yunes, Anis John Kadado, Gregory P Kaufman, Jaime Hernandez-Montfort> ;Journal of Cancer Research and Clinical Oncology. 2019 Jan 1
• 2 citations
  A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refra...
  Shira Dinner, Tamara J. Dunn, Elizabeth A. Price, Steven Coutre, Jason Gotlib, Caroline Berube, Gregory P. Kaufman, Bruno C. Medeiros, Michaela Liedtke> ;International Journal of Hematology. 2018 Sep 1
• 176 citations
  Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis
  Gregory P. Kaufman, Stanley L. Schrier, Richard A. Lafayette, Sally Arai, Ronald M. Witteles, Michaela Liedtke> ;Blood. 2017 Aug 17
• 19 citations
  Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cells
  Juan J Gu, Gregory P. Kaufman, Cory Mavis, Myron S. Czuczman, Francisco J. Hernandez-Ilizaliturri> ;Oncotarget. 2017 Feb 21
• 49 citations
  Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma.
  Gregory P. Kaufman, Morie A. Gertz, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, David Dingli, Suzanne R. Hayman, Prashant Kapoor, John A. Lust, Stephen J. Ru...> ;Leukemia. 2016 Mar 1
• 62 citations
  Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis
  Gregory P. Kaufman, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Nelson Leung, David Dingli, John A. Lust, Yi Lin, Prashant...> ;American Journal of Hematology. 2015 Mar 1
• 16 citations
  Progressive multifocal leukoencephalopathy: a rare infectious complication following allogeneic hematopoietic cell transplantation (HCT).
  Gregory P. Kaufman, Allen J. Aksamit, Christopher J. Klein, Eunhee S. Yi, David R. DeLone, Mark R. Litzow> ;European Journal of Haematology. 2014 Jan 1
• 32 citations
  The novel proteasome inhibitor carfilzomib induces cell cycle arrest, apoptosis and potentiates the anti‐tumour activity of chemotherapy in rituximab‐resistant lymphoma
  Juan J Gu, Francisco J. Hernandez-Ilizaliturri, Gregory P. Kaufman, Natalie M Czuczman, Cory Mavis, Joseph J. Skitzki, Myron S. Czuczman> ;British Journal of Haematology. 2013 Sep 1
• Join now to see all

Abstracts/Posters

• A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)
  Gregory P. Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep Responses
  Gregory P. Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Re...
  Gregory P. Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)
  Gregory P. Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL Amyloidosis
  Gregory P. Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all